Table 2

SUCRA values and heterogeneity

SUCRA value
Pain	CCS	CTL	HA	NS	PRP	HA+PRP	I² (%)
2–4 months	0.858	0.534	0.731	0.325	0.232	0.320	78.5
6 months	0.320	NR	0.497	0.536	0.715	0.431	56.6
Function
2–4 months	0.901	0.447	0.698	0.510	0.210	0.196	52.7
6 months	0.281	NR	0.651	0.359	0.581	0.628	67.4

CCS, corticosteroids; CTL, control; HA, hyaluronic acid; NR, not recorded; NS, normal saline; PRP, platelet-rich plasma; SUCRA, surface under the cumulative ranking curve.